Table 1.
Baseline characteristics of the study population
| Control (n = 8) | MDD (n = 8) | Control vs MDD p-value | ||
|---|---|---|---|---|
| Main characteristics | ||||
| Age (years) | Mean ± SE | 37.4 ± 6.5 | 38.1 ± 6.5 | 0.916 |
| Min-Max | 16–60 | 14–62 | ||
| Weigth (mg) | Mean ± SE | 78.8 ± 8.6 | 79.4 ± 4.8 | 0.317 |
| Min-Max | 64–137 | 68–110 | ||
| Post Mortem Interval (hours) | Mean ± SE | 13.1 ± 2.3 | 18.2 ± 2.2 | 0.171 |
| pH | Mean ± SE | 6.6 ± 0.1 | 6.7 ± 0.1 | 0.295 |
| RIN score | Mean ± SE | 7.7 ± 0.2 | 7.7 ± 0.2 | 0.473 |
| Sex (Male) | n (%) | 8 (100.0) | 8 (100.0) | NA |
| Race | ||||
| Ethnicity Caucasian, n (%) | n(%) | 3 (37.5) | 3 (37.5) | 0.644 |
| Ethnicity African American, n (%) | n (%) | 3 (37.5) | 1 (12.5) | |
| Ethnicity White, n (%) | n (%) | 1 (12.5) | 2 (25.0) | |
| Ethnicity Hispanic, n (%) | n (%) | 1 (12.5) | 2 (25.0) | |
| Axis I | ||||
| MDD | n (%) | 0 (0.0) | 8 (100.0) | NA |
| none | n (%) | 8 (100.0) | 0 (0.0) | |
| Toxicology/treatments | ||||
| Clear | n (%) | 4 (50.0) | 3 (37.5) | 0.534 |
| CO | n (%) | 1 (12.5) | 0 (0.0) | |
| Analgesics | n (%) | 0 (0.0) | 1 (12.5) | |
| Cannabinoid | n (%) | 0 (0.0) | 1 (12.5) | |
| none | n (%) | 3 (37.5) | 3 (37.5) | |
Data are the mean ± SEM. p-values of main characteristics are displayed in the Wilcoxon rank-sum test. p-values of Races, Axis I and toxicology are displayed in chi-squared test
CO carbon monoxide, MDD major depressive disorder, PMI postmortem interval in hours, RIN RNA integrity number